Recent discussions in the media about autism emphasize that autism biology is complex and very hard to diagnose. We agree.
Our current system is failing families. Children are often not diagnosed until around age five, because the current method of diagnosis is slow, subjective, and bottlenecked by waitlists. Those lost years are critical: earlier intervention is the proven, most beneficial way to improve outcomes for children with autism — but early intervention relies on earlier detection. Physicians and families have been waiting for science-based insight that is objective and can enable early treatment, before families lose precious years to delay.
ASD Insight™ does exactly as its name suggests. The test identifies risk factors of autism from a small skin sample. Decades of underlying research behind ASD Insight support what has long been missing: a sign of autism risk that is detectable and present in the body from birth.
We take our mission seriously: delivering scientifically rigorous, biology-based insights to families, enabling earlier action and brighter futures for children.
Sincerely,
Dave Justus & John J. (Jay) Gargus, MD, PhD
For more information, visit www.neuroqure.com.